Essai clinique NCT06422546 · Non Small Cell Lung Cancer
NCT06422546 — est «en recrutement» sur ClinicalTrials.gov.
Essai clinique NCT06422546 est «en recrutement» sur ClinicalTrials.gov.
Pathologie: Non Small Cell Lung Cancer · Dates enregistrées (source): 2022-01-13, 2027-06-30, 2024-05-21, 2026-11-06.
Résumé de l’étude (source : ClinicalTrials.gov, texte original en anglais):
A prospective ,multicenter ,non-interventional ,real-world study observing changes in molecular markers after three weeks of osimertinib targeted therapy in EGFRm NSCLC